Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Dow closed Thursday up 146 points, 0.5%, at 31,656, while the Nasdaq Composite lost 31 points, 0.3%, to 11,785 and the S&P 500 added 12...
“The opportunity to advance our proprietary psilocin compounds in multiple human trials puts Lobe in a leading position within the...
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering